Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

被引：57

作者：

Le Burel, Sebastien ^{[1
]}

Champiat, Stephane ^{[2
,3
]}

Routier, Emilie ^{[4
]}

Aspeslagh, Sandrine ^{[2
]}

Albiges, Laurence ^{[5
]}

Szwebel, Tali-Anne ^{[6
]}

Michot, Jean-Marie ^{[2
]}

Chretien, Pascale ^{[7
]}

Mariette, Xavier ^{[8
,9
,10
,11
]}

Voisin, Anne-Laure ^{[12
]}

Lambotte, Olivier ^{[1
,9
,10
,11
]}

机构：

[1] Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France

[2] Univ Paris Saclay, Gustave Roussy, DITEP, Villejuif, France

[3] INSERM, U981, Villejuif, France

[4] Inst Gustave Roussy, Dept Dermatol, Villejuif, France

[5] Inst Gustave Roussy, Dept Oncol Med, Villejuif, France

[6] Hop Cochin, AP HP, Serv Med Interne, Paris, France

[7] Hop Bicetre, AP HP, Immunol Lab, Le Kremlin Bicetre, France

[8] Hop Bicetre, AP HP, Serv Rhumatol, Le Kremlin Bicetre, France

[9] INSERM, U1184, Immunol Viral Infect & Autoimmune Dis, Le Kremlin Bicetre, France

[10] Univ Paris Sud, UMR 1184, Le Kremlin Bicetre, France

[11] CEA, DSV iMETI, IDMIT, Fontenay Aux Roses, France

[12] Inst Gustave Roussy, Unite Fonct Pharmacovigilance, Villejuif, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷 / 03期

关键词：

IMMUNE CHECKPOINT BLOCKADE;

D O I：

10.1136/annrheumdis-2016-210820

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：468 / 470

页数：3

共 6 条

[1]

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination [J].

Boutros, Celine ;

Tarhini, Ahmad ;

Routier, Emilie ;

Lambotte, Olivier ;

Ladurie, Francois Leroy ;

Carbonnel, Franck ;

Izzeddine, Hassane ;

Marabelle, Aurelien ;

Champiat, Stephane ;

Berdelou, Armandine ;

Lanoy, Emilie ;

Texier, Matthieu ;

Libenciuc, Cristina ;

Eggermont, Alexander M. M. ;

Soria, Jean-Charles ;

Mateus, Christine ;

Robert, Caroline .

NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) :473-486

[2]

Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases [J].

Calabrese, Leonard ;

Velcheti, Vamsidhar .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :1-3

[3]

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab [J].

Cappelli, Laura C. ;

Gutierrez, Anna Kristina ;

Baer, Alan N. ;

Albayda, Jemima ;

Manno, Rebecca L. ;

Haque, Uzma ;

Lipson, Evan J. ;

Bleich, Karen B. ;

Shah, Ami A. ;

Naidoo, Jarushka ;

Brahmer, Julie R. ;

Le, Dung ;

Bingham, Clifton, III .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :43-50

[4]

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper [J].

Champiat, S. ;

Lambotte, O. ;

Barreau, E. ;

Belkhir, R. ;

Berdelou, A. ;

Carbonnel, F. ;

Cauquil, C. ;

Chanson, P. ;

Collins, M. ;

Durrbach, A. ;

Ederhy, S. ;

Feuillet, S. ;

Francois, H. ;

Lazarovici, J. ;

Le Pavec, J. ;

De Martin, E. ;

Mateus, C. ;

Michot, J. -M. ;

Samuel, D. ;

Soria, J. -C. ;

Robert, C. ;

Eggermont, A. ;

Marabelle, A. .

ANNALS OF ONCOLOGY, 2016, 27 (04) :559-574

[5]

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab [J].

Menzies, A. M. ;

Johnson, D. B. ;

Ramanujam, S. ;

Atkinson, V. G. ;

Wong, A. N. M. ;

Park, J. J. ;

McQuade, J. L. ;

Shoushtari, A. N. ;

Tsai, K. K. ;

Eroglu, Z. ;

Klein, O. ;

Hassel, J. C. ;

Sosman, J. A. ;

Guminski, A. ;

Sullivan, R. J. ;

Ribas, A. ;

Carlino, M. S. ;

Davies, M. A. ;

Sandhu, S. K. ;

Long, G. V. .

ANNALS OF ONCOLOGY, 2017, 28 (02) :368-376

[6]

Michot, J. M. ;

Bigenwald, C. ;

Champiat, S. ;

Collins, M. ;

Carbonnel, F. ;

Postel-Vinay, S. ;

Berdelou, A. ;

Varga, A. ;

Bahleda, R. ;

Hollebecque, A. ;

Massard, C. ;

Fuerea, A. ;

Ribrag, V. ;

Gazzah, A. ;

Armand, J. P. ;

Amellal, N. ;

Angevin, E. ;

Noel, N. ;

Boutros, C. ;

Mateus, C. ;

Robert, C. ;

Soria, J. C. ;

Marabelle, A. ;

Lambotte, O. .

EUROPEAN JOURNAL OF CANCER, 2016, 54 :139-148

← 1 →